NCT04334889

Brief Summary

Participants will perform movements while receiving different visual cues. Spinal kinematics will be measured during these movements and compared between asymptomatic and CLBP participants. Participants will come for a unique session.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2025

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 2, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 6, 2020

Completed
5.5 years until next milestone

Study Start

First participant enrolled

October 1, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

September 30, 2025

Status Verified

September 1, 2025

Enrollment Period

6 months

First QC Date

April 2, 2020

Last Update Submit

September 25, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Spinal kinematics

    Spinal kinematics will be measured at the lumbar and thoracic spine in degrees

    Day 1

Study Arms (2)

Chronic low back pain (CLBP)

All CLBP patients should present with non-specific low back pain (pain from lower ribs to gluteal folds) for more than 3 months.

Other: Visual cues

Asymptomatic controls

Asymptomatic participants should have had no history of LBP requiring medical attention during the last two years and no other concomitant pain or condition that could compromise the evaluation of lumbar kinematics.

Other: Visual cues

Interventions

Participants will be asked to move following cues displayed on a screen in front of them.

Asymptomatic controlsChronic low back pain (CLBP)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

CLBP patients will be recruited through a multimodal rehabilitation program at Lausanne University Hospital, medical doctors or physiotherapists' consultations. Healthy controls will be a convenience sample recruited using flyers and emails, notably posted at the Lausanne University Hospital, the University of Health Professions in Lausanne (HESAV) and at the University of Lausanne.

You may qualify if:

  • \- sufficient French level to understand the instructions for the tests, the information sheet, the consent form.
  • For CLBP patients:
  • \- diagnosis of non-specific low back pain (pain from lower ribs to gluteal folds) for more than 3 months.
  • For asymptomatic participants:
  • no history of LBP requiring medical attention during the last two years
  • no other concomitant pain or condition that could compromise the evaluation of lumbar kinematics.

You may not qualify if:

  • pregnancy
  • skin allergy to tape
  • body mass index (BMI) above 32
  • For patients with CLBP only:
  • specific low back pain (such as the presence of infection, rheumatological or neurological diseases, spinal fractures, tumours)
  • any known important spinal deformities
  • previous back surgery that limits spinal mobility
  • high level of pain at the time of experiment that prevents repeated movements (severity and irritability)
  • other concomitant pain or condition that could compromise the evaluation of spinal kinematics.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Low Back Pain

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Julien Favre, PhD

CONTACT

Guillaume Christe, MSc

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 2, 2020

First Posted

April 6, 2020

Study Start

October 1, 2025

Primary Completion

April 1, 2026

Study Completion

April 1, 2026

Last Updated

September 30, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share